Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Bend Research has entered into a collaboration with Vertex Pharmaceuticals (Vertex) according to which Bend provides novel formulation developement and manufacturing services for specific vertex-led projects and clinical trials to Vertex.
Subscribe to our email newsletter
As per the agreement, Vertex will utilise Bend’s formulation development and manufacturing services for specific projects and clinical trials, with the goals of both enhancing the delivery of Vertex compounds and supporting the progression of certain Vertex product candidates through clinical development.
The collaboration is designed to leverage the fundamental scientific capabilities of each company to solve formulation and process-development challenges and to produce commercial drug products that are optimised for therapeutic benefit.
Peter Mueller, EVP of global research and development and chief scientific officer, said: “Our collaboration with Bend Research exemplifies Vertex’s commitment to the treatment of serious diseases through cutting-edge science and innovative technologies.”